Text Size
1417 studies found for:    Farber's Disease

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Unknown † Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease
Condition: Graft Versus Host Disease
Interventions: Biological: daclizumab;   Drug: methylprednisolone
2 Recruiting Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination
Condition: Chronic Lymphocytic Leukemia
Interventions: Biological: GM-K562 vaccine;   Procedure: stem cell transplantation
3 Unknown † Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors
Conditions: Hodgkin's Disease;   Breast Cancer
Intervention: Drug: Tamoxifen
4 Unknown † Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation
Condition: Veno-Occlusive Disease
Intervention: Drug: defibrotide
5 Completed Mantle Irradiation for Hodgkin's Disease
Condition: Hodgkin's Disease
Intervention: Procedure: Mantle irradiation
6 Completed Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease
Conditions: Breast Cancer;   Hodgkin's Disease
Interventions: Procedure: breast MRI;   Procedure: Mammogram
7 Completed Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation
Conditions: Acute Myelogenous Leukemia;   Graft Versus Host Disease;   Acute Lymphoblastic Leukemia;   Chronic Myelogenous Leukemia;   Myelodysplastic Syndromes;   Non-Hodgkin's Lymphoma;   Hodgkin's Disease
Interventions: Drug: sirolimus;   Drug: tacrolimus
8 Completed Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease
Condition: Graft vs Host Disease
Intervention: Drug: Rituximab
9 Completed Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation
Conditions: Hematologic Malignancies;   Myelogenous Leukemia;   Acute Lymphoblastic Leukemia;   Myelodysplastic Syndrome;   Non-Hodgkin's Lymphoma;   Hodgkin's Disease
Interventions: Drug: Sirolimus;   Drug: Tacrolimus
10 Active, not recruiting Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation
Condition: Hodgkin's Disease
Intervention: Procedure: Echocardiogram Stress Test
11 Completed Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation
Conditions: Graft Versus Host Disease;   Hematologic Malignancies
Interventions: Drug: Sirolimus;   Drug: Tacrolimus;   Drug: Methotrexate;   Procedure: Stem Cell Transplantation
12 Terminated Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease
Condition: Lung Cancer
Intervention: Procedure: chest computed tomography scan
13 Completed Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host Disease
Condition: Chronic Graft Versus Host Disease
Interventions: Drug: bortezomib;   Drug: Prednisone
14 Completed Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease
Condition: Graft Versus Host Disease
Intervention: Drug: Interleukin-2
15 Recruiting Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
Condition: Chronic Graft-versus-host Disease
Intervention: Drug: Interleukin-2
16 Completed Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: Lexiscan
17 Unknown † Laboratory-Treated Peripheral Blood Cell Infusion After Donor Stem Cell Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: anti-thymocyte globulin;   Biological: peripheral blood lymphocyte therapy;   Drug: fludarabine phosphate;   Drug: methylprednisolone;   Drug: thiotepa;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: in vitro-treated peripheral blood stem cell transplantation;   Radiation: total-body irradiation
18 Active, not recruiting Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease
Condition: Chronic Graft-versus-host Disease
Intervention: Drug: Alefacept
19 Recruiting Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant
Condition: Graft Versus Host Disease
Interventions: Drug: Tacrolimus;   Drug: Methotrexate;   Drug: Bortezomib;   Drug: Sirolimus
20 Recruiting T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)
Condition: Breast Cancer
Interventions: Drug: Trastuzumab;   Drug: Paclitaxel;   Drug: Trastuzumab emtansine
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years